These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 25834048)

  • 61. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
    Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
    Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ellagic Acid Inhibits α-Synuclein Aggregation at Multiple Stages and Reduces Its Cytotoxicity.
    Kumar S; Kumar R; Kumari M; Kumari R; Saha S; Bhavesh NS; Maiti TK
    ACS Chem Neurosci; 2021 Jun; 12(11):1919-1930. PubMed ID: 34015214
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of alpha-synuclein phosphorylation at Serine 129 in methamphetamine-induced neurotoxicity in vitro and in vivo.
    Ding J; Wang Y; Huang J; Lian Y; Meng Y; Li C; He Y; Qiu P
    Neuroreport; 2020 Aug; 31(11):787-797. PubMed ID: 32568772
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity.
    Emadi S; Barkhordarian H; Wang MS; Schulz P; Sierks MR
    J Mol Biol; 2007 May; 368(4):1132-44. PubMed ID: 17391701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential effects of Cu
    Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
    Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's disease.
    Oueslati A; Paleologou KE; Schneider BL; Aebischer P; Lashuel HA
    J Neurosci; 2012 Feb; 32(5):1536-44. PubMed ID: 22302797
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Copper Binding and Subsequent Aggregation of α-Synuclein Are Modulated by N-Terminal Acetylation and Ablated by the H50Q Missense Mutation.
    Mason RJ; Paskins AR; Dalton CF; Smith DP
    Biochemistry; 2016 Aug; 55(34):4737-41. PubMed ID: 27517125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 70. KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity.
    Dettmer U; Newman AJ; von Saucken VE; Bartels T; Selkoe D
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9596-601. PubMed ID: 26153422
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
    Van Rompuy AS; Oliveras-Salvá M; Van der Perren A; Corti O; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2015 Jun; 10():23. PubMed ID: 26099628
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Seeded propagation of α-synuclein aggregation in mouse brain using protein misfolding cyclic amplification.
    Nicot S; Verchère J; Bélondrade M; Mayran C; Bétemps D; Bougard D; Baron T
    FASEB J; 2019 Nov; 33(11):12073-12086. PubMed ID: 31370680
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.
    Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF
    Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414
    [TBL] [Abstract][Full Text] [Related]  

  • 74. α-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to β-Spectrin.
    Maor G; Dubreuil RR; Feany MB
    J Neurosci; 2023 Mar; 43(9):1614-1626. PubMed ID: 36653193
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.
    Prabhudesai S; Sinha S; Attar A; Kotagiri A; Fitzmaurice AG; Lakshmanan R; Ivanova MI; Loo JA; Klärner FG; Schrader T; Stahl M; Bitan G; Bronstein JM
    Neurotherapeutics; 2012 Apr; 9(2):464-76. PubMed ID: 22373667
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits.
    Gezer AO; Kochmanski J; VanOeveren SE; Cole-Strauss A; Kemp CJ; Patterson JR; Miller KM; Kuhn NC; Herman DE; McIntire A; Lipton JW; Luk KC; Fleming SM; Sortwell CE; Bernstein AI
    Neurobiol Dis; 2020 Jul; 141():104947. PubMed ID: 32422283
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
    Fredenburg RA; Rospigliosi C; Meray RK; Kessler JC; Lashuel HA; Eliezer D; Lansbury PT
    Biochemistry; 2007 Jun; 46(24):7107-18. PubMed ID: 17530780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity.
    Kim TE; Newman AJ; Imberdis T; Brontesi L; Tripathi A; Ramalingam N; Fanning S; Selkoe D; Dettmer U
    Hum Mol Genet; 2021 Nov; 30(23):2332-2346. PubMed ID: 34254125
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
    Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
    Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.